(Press-News.org) In a new study published in Proceedings of the National Academy of Sciences USA, researchers at the University of Alberta's Faculty of Medicine & Dentistry have explained how the function of a key protein in the heart changes in heart failure.
Heart disease is the number-one killer in the developed world. The end stage of heart disease is heart failure, in which the heart cannot pump enough blood to satisfy the body's needs. Patients become progressively short of breath as the condition worsens, and they also begin to accumulate fluid in the legs and lungs, making it even more difficult to breathe.
The molecular structure of the heart muscle changes as heart failure progresses, though scientists cannot always agree on what changes are good or bad. One change that occurs is an increase in "calcium sensitivity". Calcium ions are pumped in and out of the muscle cell with each heartbeat, turning contractions on and off. When the calcium sensitivity increases, contractility increases, but at a price: the relaxation of the heart becomes slower. Both phases of cardiac function are important: impaired contraction leads to systolic heart failure, while impaired relaxation leads to diastolic heart failure. Both types of heart failure are similar in terms of overall prevalence, symptoms and mortality.
Since 1976 medical researchers have known that the heart regulates its calcium sensitivity by phosphorylating (adding negative phosphate groups) to a key cardiac protein called troponin I. The troponin complex is made up of three proteins, C, I, and T, which trigger muscle contraction in response to calcium. In heart failure, the phosphate groups are removed from troponin I, but it wasn't known how this caused an increase in calcium sensitivity.
Peter Hwang, an assistant professor in the Department of Medicine, working with professor Brian Sykes in the Department of Biochemistry at the University of Alberta, studied the troponin complex with nuclear magnetic resonance (NMR) spectroscopy, a powerful method that uses superconducting magnets to probe atomic level structure. They observed that unphosphorylated troponin I binds to troponin C to keep it in an optimal orientation for triggering contraction. The (N-terminal) region of troponin I that interacts with troponin C is very positively charged, while troponin C is very negatively charged, so adding negative phosphate groups to troponin I disrupts the interaction and releases troponin C so that it becomes less efficient at triggering contraction.
"Scientists believed that the dephosphorylation of troponin I seen in heart failure somehow caused the troponin complex to become less functional," says Hwang, lead author in the study. "Actually, the change brings it into the optimal alignment to trigger contraction. The heart has other mechanisms of regulating calcium sensitivity that probably also act by stabilizing or disrupting this arrangement."
Hwang hypothesizes that the heart continuously adjusts calcium sensitivity in order to maintain a proper balance between contraction and relaxation.
"I believe that calcium sensitivity will become a central concept in cardiology. The increase in calcium sensitivity seen in heart failure may be the heart's response to ongoing volume or pressure overload. While this would be a beneficial compensation in the setting of systolic heart failure, it is probably not helpful in diastolic heart failure. A Heart and Stroke Foundation grant is now allowing our team to develop troponin-targeting drugs that modulate calcium sensitivity for the treatment of heart failure. We will see if this hypothesis is correct."
INFORMATION:
University of Alberta researchers explain 38-year-old mystery of the heart
2014-09-29
ELSE PRESS RELEASES FROM THIS DATE:
Good working relationships between clients, bankers can reduce defaults
2014-09-29
You've probably seen advertising campaigns in which banks describe how much their customer relationships matter to them. While such messaging might have been cooked up at an ad agency, it turns out there is some truth underlying these slogans.
As a newly published study co-authored by an MIT professor shows, strong working relationships between bankers and clients reduce the likelihood of loan delinquencies and defaults, at least in the context of an emerging economy.
Using propriety data from a large bank in Chile, the study finds that when loan officers go on leave, ...
Causes of California drought linked to climate change
2014-09-29
The atmospheric conditions associated with the unprecedented drought currently afflicting California are "very likely" linked to human-caused climate change, Stanford scientists say.
In a new study, a team led by Stanford climate scientist Noah Diffenbaugh used a novel combination of computer simulations and statistical techniques to show that a persistent region of high atmospheric pressure hovering over the Pacific Ocean that diverted storms away from California was much more likely to form in the presence of modern greenhouse gas concentrations.
The research, published ...
Decision to reintroduce aprotinin in cardiac surgery may put patients at risk
2014-09-29
Cardiac surgery patients may be at risk because of the decision by Health Canada and the European Medicines Agency to reintroduce the use of aprotinin after its withdrawal from the worldwide market in 2007, assert the authors of a previous major trial that found a substantially increased risk of death associated with the drug. In an analysis in CMAJ (Canadian Medical Association Journal), the authors refute three major criticisms of the trial made by the regulatory bodies.
Aprotinin, used to control bleeding in cardiac surgery, was withdrawn worldwide in 2007 after the ...
Revolutionary hamstring tester will keep more players on the field
2014-09-29
Elite sporting stars can assess and reduce their risk of a hamstring injury thanks to a breakthrough made by QUT researchers.
The discovery could be worth a fortune to football codes, with hamstring strain injuries accounting for most non-contact injuries in Australian rules football, football and rugby union, as well as track events like sprinting.
Using an innovative field device, a research team led by Dr Anthony Shield, from QUT's School - Exercise and Nutrition Sciences, and former QUT PhD student, Dr David Opar, now at the Australian Catholic University, measured ...
Drug for kidney injury after cardiac surgery does not reduce need for dialysis
2014-09-29
Among patients with acute kidney injury after cardiac surgery, infusion with the antihypertensive agent fenoldopam, compared with placebo, did not reduce the need for renal replacement therapy (dialysis) or risk of death at 30 days, but was associated with an increased rate of abnormally low blood pressure, according to a study published in JAMA. The study is being posted early online to coincide with its presentation at the European Society of Intensive Care Medicine annual congress.
More than 1 million patients undergo cardiac surgery every year in the United States ...
Climate detectives reveal handprint of human caused climate change in Australia
2014-09-29
Australia's hottest year on record in 2013 along with the accompanying droughts, heat waves and record-breaking seasons of that year was virtually impossible without the influence of human-caused global warming.
New research from ARC Centre of Excellence for Climate System Science (ARCCSS) researchers and colleagues, over five different Australian papers in a special edition of the Bulletin of the American Meteorological Society (BAMS), has highlighted the powerful influence of global warming on Australia's climate.
"We often talk about the fingerprint of human-caused ...
Rising prevalence of sleep apnea in US threatens public health
2014-09-29
DARIEN, IL – Public health and safety are threatened by the increasing prevalence of obstructive sleep apnea, which now afflicts at least 25 million adults in the U.S., according to the National Healthy Sleep Awareness Project. Several new studies highlight the destructive nature of obstructive sleep apnea, a chronic disease that increases the risk of high blood pressure, heart disease, Type 2 diabetes, stroke and depression.
"Obstructive sleep apnea is destroying the health of millions of Americans, and the problem has only gotten worse over the last two decades," said ...
Targeted combination therapy halts disease, extends life in advanced melanoma patients
2014-09-29
A world-first study in today's New England Journal of Medicine heralds the efficacy of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metastatic melanoma.
The multi-centre, double-blind, randomised, phase 3 trial compared oral dabrafenib (150 mg twice daily) and oral trametinib (2 mg once daily) combination therapy with oral dabrafenib (150 mg twice daily) and placebo.
All trial patients had inoperable stage 3C or 4 metastatic melanoma that had a BRAF gene mutation V600E or V600K. Among ...
Investigating the 'underground' habitat of Listeria bacteria
2014-09-29
The literature describes Listeria as ubiquitous bacteria with widespread occurrence. Yet they only become a problem for humans and animals when they contaminate food processing facilities, multiply, and enter the food chain in high concentrations. An infection with Listeria monocytogenes can even be fatal for humans or animals with weakened immune systems.
Listeria in soil or water are not dangerous
"Listeria in soil or water represent a relatively low risk to humans," explains study director Beatrix Stessl. "The concentrations are too low. The aim of our study was ...
Trial shows trastuzumab should remain as standard of care for HER2-positive breast cancer
2014-09-29
JACKSONVILLE, Fla., Sept. 29, 2014 — Analysis of more than 8,000 women who participated in the world's largest study of two treatments for HER2-positive breast cancer reinforces other findings from the clinical trial showing that trastuzumab (Herceptin) should remain the standard of care for this cancer, says a Mayo Clinic researcher.
This study, being presented at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, reveals that when used as a single HER2-targeted therapy in addition to standard chemotherapy, trastuzumab offers a better outcome than ...